Search results
Results from the WOW.Com Content Network
The BNF for Children developed from the British National Formulary (BNF), which prior to 2005 had provided information on the treatment of children, with the doses largely determined by calculations based on the body weight of the child. The guidance was provided by pharmacists and doctors whose expertise was in the care of adults.
The fifth version in 1957 saw its name change to The British National Formulary. [ 4 ] [ 5 ] A new-look version, under the auspices of Owen Wade , was released in 1981. [ 2 ] [ 6 ] A study in Northern Ireland, looking at prescribing in 1965, reported that the BNF was likely able to serve the requirements of prescribers in general practice ...
The two main reference sources providing this information are the British National Formulary (BNF) and the Drug Tariff. There is a section in the Drug Tariff, known unofficially as the " Blacklist ", detailing medicines which are not to be prescribed under the NHS and must be paid for privately by the patient.
British National Formulary and British National Formulary for Children – the UK standard reference in the use and selection of medicines, published in conjunction with the BMJ Group.
The British Pharmacopoeia is an important statutory component in the control of medicines, which complements and assists the licensing and inspection processes of the UK's Medicines and Healthcare products Regulatory Agency (MHRA). Together with the British National Formulary (BNF), the British Pharmacopoeia defines the UK's pharmaceutical ...
In 1963 Edward G Feldmann, director of revision for the US National Formulary, described it as "a compilation of highly authoritative and useful therapeutic (actions and doses) information as well as a valuable compendium of recognised standards and specifications". [2] In 1979 a new edition was published with a new title, The Pharmaceutical Codex.
In July 2023, MHRA began a consultation to reclassify cough syrups containing codeine (an opiate) as prescription-only medicines, in response to a rise in recreational drug abuse cases since 2018. There were 277 serious and fatal reactions to medicines containing codeine in 2021, and 243 in 2022.
The Pharmaceutical Society of Great Britain was founded on 15 April 1841 [1] by William Allen FRS, Jacob Bell, Daniel Hanbury, John Bell, Andrew Ure, James Marwood Hucklebridge, and other London chemists and druggists, at a meeting in the Crown and Anchor Tavern, Strand, London.